Bal Pharma share news, announcements and annual reports
NSE: BALPHARMABSE: 524824Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹84.61.
30 Oct: open ₹84.05, high ₹84.05, low ₹81.21
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹130 Cr2,779th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 18.08
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.58
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.47%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.94
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,401
Bal Pharma results
77 filed, newest first. Page 1 of 2.
Aug 2026
May 2026
27 May · Results
Feb 2026
11 Feb · Results
Nov 2025
12 Nov · Results
Aug 2025
11 Aug · Results
Feb 2025
13 Feb · Results
Nov 2024
14 Nov · Results
Aug 2024
12 Aug · Results
May 2024
28 May · Results
Feb 2024
12 Feb · Results
Nov 2023
8 Nov · Results
Aug 2023
11 Aug · Results
May 2023
29 May · Results
Feb 2023
6 Feb · Results
May 2022
31 May · Results
Feb 2022
10 Feb · Results
Jan 2022
Nov 2021
11 Nov · Results
Oct 2021
Aug 2021
10 Aug · Results
10 Aug · Results
Jul 2021
2 Jul · Results
Jun 2021
29 Jun · Results
29 Jun · Results
Feb 2021
11 Feb · Results
Nov 2020
11 Nov · Results
Sep 2020
8 Sep · Results
Aug 2020
3 Aug · Results
Jul 2020
29 Jul · Results
Feb 2020
12 Feb · Results
Nov 2019
14 Nov · Results
Aug 2019
13 Aug · Results
Jun 2019
May 2019
31 May · Results
Feb 2019
13 Feb · Results
Nov 2018
19 Nov · Results
14 Nov · Results
Aug 2018
10 Aug · Results
May 2018
30 May · Results
Feb 2018
14 Feb · Results
Dec 2017
11 Dec · Results
Sep 2017
11 Sep · Results
May 2017
30 May · Results
Feb 2017
7 Feb · Results
Nov 2016
14 Nov · Results
Aug 2016